Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
Experts convened by the National Institutes of Health (NIH) have identified five elements of a brain-based condition that has emerged as a leading cause of vision impairment starting in childhood in the United States and other industrialized nations.
The National Eye Institute (NEI) hosted its annual Focus on Fellows retreat on October 17-18, 2024, bringing together NEI trainees—graduate students, postbac fellows, and postdoctoral researchers—to enhance collaboration and foster career growth.
Researchers today are releasing the flagship dataset from an ambitious study of biomarkers and environmental factors that might influence the development of type 2 diabetes, which is associated with a range of eye diseases such as diabetic retinopathy..
Research team has identified advanced preclinical candidates targeting the bisretinoid synthesis pathway, which could help treat macular degeneration and Stargardt disease.
New research suggests long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of shingles-related eye inflammation, infection, and pain.
Too much stuff in the periphery of our vision can make it difficult to identify what we’re seeing. Yale researchers now know how that clutter affects the brain.
New research from the University of Rochester provides important insights into the cellular mechanisms behind AMD and offers potential avenues for new treatments.
Scientists at the National Eye Institute and their colleagues have identified a gene responsible for some inherited retinal diseases (IRDs), which are a group of disorders that damage the eye’s light-sensing retina and threatens vision.